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1. Introduction 
In vertebrates, protohaem is catabolised via biliver- 
din to bilirubin. Since the bilirubin formed is almost 
entirely the IX (II isomer [ 1] it is generally accepted 
that the initial step of haem catabolism involves clea- 
vage specifically at the cu-methine bridge to yield bili- 
verdin IX&. (See scheme 1; the IX& IX-/ and IX6 iso- 
mers of biliverdin would be produced respectively by 
cleavage at the 0,~ and Gmethine bridges). 
The mechanism of the specific in uivo cleavage isa 
controversial issue of long standing. Lemberg [2,3] 
many years ago advocated a mechanism similar to the 
non-enzymatic nvitro coupled oxidations of pyridine 
haemochrome and haemproteins with ascorbate, the 
products of which may be readily converted to bili- 
verdin. However, this idea fell into disfavour with the 
demonstration that the coupled oxidation of pyridine 
haemochrome involves random cleavage of the methine 
bridges rather than specific cleavage at the Q bridge 
[4,5]. Workers in the field have since concentrated on 
the search for an enzyme system which would speci- 
fically cleave heam or some derivative of it at the (Y- 
methine bridge. The problem seemed to have been 
solved by the work of Nakajima nd coworkers, who 
in an extensive series of papers (e.g. Refs. 6-9) des- 
cribed a soluble hepatic enzyme “haem cw-methenyl 
oxygenase” which was claimed to caialyse the cleavage 
of pyridine haemochrome specifically at the 1y bridge 
to yield a precursor of biliverdin IXCV. 
However, our investigations, after exhaustive re- 
checking, [10,11,12] have convinced us that the hae- 
mochrome-cleaving activity described by Nakajima et 
al. is entirely non-enzymatic and due to coupled oxida- 
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dation of the haemochrome with endogenous ascorbate. 
This reaction seems to be similar in all respects to 
the in vitro system described many years previously. 
Other workers have also reported their inability to con- 
firm the conclusions of Nakajima et al. [13,14,15]. 
Using our chromatographic technique of isomer anal- 
ysis described in table J, which is far more sensitive 
and discriminating than the degradation technique 
used by Nakajima [8,9] , we find that the product 
formed from pyridine haemochrome by extracts from 
liver and other tissues contains all four isomers, and 
only 30-33% of the a! isomer [ 1 l] . The in vitro 
coupled oxidation of pyridine haemochrome with as- 
corbate produces an identical mixture of isomers 
(table 1). This lack of specificity seems to rule out any 
physiological role for this system. 
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Scheme 1. (P = CH2CH2COOH). 
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Table 1 
Isomeric composition of biliverdin products. The biliierdin preparation is methylated (in 1.5 ml 5% methanolic H2SO4, 16 h, 2O, 
under N2), transferred to chloroform, washed free of acid and evaporated to dryness. It is then applied to a Silica Gel G t.1.c. plate 
and double-developed (in one dimension) with n-heptaneethyl methyl ketone-acetic acid (10:s: 1). The isomers, which separate 
in the order (front to back) 7, p, S , a [ 121, are scraped off, eluted into acetone and the relative proportions are estimated spec- 
trophotometrlcally at 650 mn. 
Haem derivative 
incubated aerobically 
with ascorbate* 
% Isomer composition of biliverdin product 
IXCY IXB 1x7 IXS 
Pyridine haemochrome 33 20 24 23 
Myoglobin 100 0 0 0 
Myoglobin in 8 M urea 32 21 25 22 
Haemoglobin 8065 20-35 0 0 
* Pyridine haemochrome: incubated and product isolated as described by Murphy et al. [lo]. Haemprotelns: 50 mg. myoglobin 
(sperm whale or horse heart metmyoglobin, crystalline) or 50 mg, haemoglobin (bovine methaemoglobin X 2 tryst. or fresh oxy- 
haemoglobin preparations) in 10 ml. 0.1 M pH 7 phosphate buffer were incubated aerobically with 10 mg. ascorbate at 37’ for 
2 hours in 50 ml. beakers. The incubation mixtures were then cooled in an ice bath, 3 ml. acetic acid and 8 ml. 5 N HCI added, 
and the remaining heamin extracted quickly into peroxide-free ether (15 X 2). The biliverdin was then extracted quickly into chlo 
roform (5 ml), and evaporated to dryness under a stream of nitrogen. 
Heamin itself does not undergo any appreciable 
coupled oxidation with reductants under physiologi- 
cal conditions and seemed a better and more natural 
substrate than pyridine haemochrome. Many tissue ex- 
tracts did in fact cleave haemin to biliverdin. However, 
we found that in general the products formed were a- 
gain non-physiological mixtures of isomers. The acti- 
vity seemed to be due to random haemochrome forma- 
tion between the haemin and exposed amino or imi- 
dazolyl groups on any proteins in the extracts, followed 
by coupled oxidation of the haemochromes with re- 
ductants such as ascorbate. 
We therefore re-investigated the direct, nonenzy- 
matic breakdown of haemproteins by coupled oxida- 
tion with ascorbate which can be carried out under 
physiological conditions of temperature, pH and oxy- 
gen tension [3,13]. Biliverdin is produced directly, 
but in haemproteins containing thiol groups (e.g. haem- 
oglobin) the latter tend to react with the very reac- 
tive vinyl side-chains of the biliverdin leaving a variable 
proportion of the pigment attached through artefact 
thioether bonds [3]. We have minimized this interac- 
tion by isolating the biliverdin formed as rapidly as 
possible (cf. table 1) but we still lose quite a propor- 
tion (30-50% in the case of bovine haemoglobin). In 
equating the isomeric composition of the isolated 
biliverdin with the relative composition of the total 
biliverdin formed, we make the assumption that the 
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four isomers interact approximately equally with the 
thiol groups as is indicated by control incubations of 
the isomers with thiolcontaining proteins. 
This problem did not arise with myoglobin, which 
contains no thiol groups, and we obtained the most 
clear-cut results with this haemprotein. The biliverdin 
formed was entirely the IXa isomer. When the reac- 
tion carried out under denaturing conditions (in 8 M 
urea) the specificity was lost and a random mixture of 
all four isomers was obtained (table 1). 
The result was unexpected since the X-ray diffrac- 
tion work of Kendrew et al. [ 171 has shown that the 
(Y bridge of the haem group of myoglobin is situated 
at the bottom of the haem-containing crevice and is 
surrounded by hydrophobic amino acid side-chains. 
The y bridge on the other hand is quite exposed and 
the /3 and S bridges are also quite accessible from the 
exterior. The specific cleavage at the cw-methine bridge 
must therefore be a positive effect of the haem-binding 
site rather than a masking of the other three bridges. 
The biliverdin obtained by coupled oxidation of 
haemoglobin was also predominantly the IXo isomer 
but always with a proportion of the Iw isomer which 
varied from 20% to 35% with different haemoglobin 
preparations and under different conditions. No traces 
of the 1x7 or IX6 isomers were formed (table 1). 
Therefore a definite specific labilization is also appa- 
rent here though the specificity is not as absolute as in 
myoglobin. 
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The 2.8 A-resolution model of haemoglobin con- 
structed by Peru& et al. [ 181 indicates that the P-me- 
thine bridge of haem is in a more hydrophobic envi- 
ronment in all four heambinding sites of haemoglobin 
than in myoglobin. Hydrophobic environments may 
therefore be the basis of the specific cleavage. Alter- 
natively, conformational interactions of the subunits 
leading to perturbations of the haem crevice during the 
coupled oxidation may be responsible for the produc- 
tion of the IX/3 isomer. We find that catalase (another 
tetrameric haemprotein) on coupled oxidation also 
yields specifically the IXcr and IXP isomers of biliver- 
din. 
Preliminary results indicate that a microsomal haem- 
protein (problably cytochrome P450 which, like myo- 
globin and haemoglobin, contains protohaem and in- 
teracts with oxygen) also undergoes coupled oxidation 
in the presence of NADPH and ascorbate with the pro- 
duction of biliverdin IXa. 
In view of these results it now seems unnecessary 
to retain the conventional concept of a haem-cleaving 
enzyme system since the haemproteins themselves 
seem to to have all the attributes being sought in such 
an enzyme system. 
The production of significant proportion of biliver- 
din 1x0 from haemoglobin may seem to conflict with 
the evidence that the bilirubin produced in vivo is al- 
most entirely the IXo isomer, particularly since haemo- 
globin breakdown contributes the bulk of this biliru- 
bin. However the yield of bilirubin from in vivo haemo- 
globin breakdown is not quantitative, varying between 
60 to 80 per cent (cf. ref. 19). The 20 to 40 per cent 
of the haemoglobin haem not accounted for as biliru- 
bin is thought o be catabolized by another oute 1191. 
This 20 to 40% discrepancy corresponds closely with 
the 20 to 35% of biliverdin IX/3 formed in our in vitro 
coupled oxidations of haemoglobin. Furthermore we 
have found that biliverdin reductase (the enzyme system 
which converts biliverdin to bilirubin) reduces biliver- 
din IXp (and also 1x7 and 1x6) at an extremely slow 
rate compared to bihverdin IX& (Colleran and O’Carra, 
unpublished). It is probable therefore that very little, 
if any, biliverdin Iw formed in vivo would appear as 
bilirubin. The production of such a proportion of bili- 
verdin IX/3 from haemoglobin may therefore take place 
in vivo also. 
Some further results uggest an alternative xplana- 
tion: When coupled oxidation of small quantities of 
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Fig. 1. (apo)Myoglobin as an &methinespecific haem-cleaving 
enzyme. Aliquots of 0.92 pmoles haemin (0); 0.15 pmoles met- 
myoglobin (0); or 0.92 rmoles haemin + 0.15 ticmoles metmyo- 
globin (0) were incubated aerobically in 50 ml. beakers with 10 
mg. ascorbate in 6 ml. O.lM phosphate buffer pH 7 for the in- 
dicated periods of time. (A separate incubation mixture was set 
up for each time point; the haemin was added as 1 ml. of a so- 
lution made by dissolving 6 mg. of haemin in 0.1 ml. of 5% so- 
dium carbonate and diluting to 10 ml. with O.lM phosphate 
buffer pH 7). The biliverdin product was isolated as described 
in table 1, the chloroform extract evaporated under nitrogen to 
c. 0.5 ml., made up to 2 ml. with chloroform and the absorb- 
ancy at 650 nm measured. These values were plotted directly 
as absorbancy units vs. time of incubation. The biliverdin ali- 
quots were subsequently analysed for their isomer composition 
as described in table 1. The biliverdin produced from myoglo- 
bin is almost entirely IX& that from haemin + myoglobin is o- 
ver 95% IX& while the trace of biliverdin produced from hae- 
min alone is a random mixture. The lag phase in the curves ap- 
pears to be caused by the necessary conversion of most of the 
metmyoglobin to oxymyoglobin. The levelling-out of the curve 
for myoglobin alone after 3 to 4 hours corresponds with essen- 
tially complete disappearance of its haem complement. 
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myoglobin or haemoglobin was carried out in the pre- 
sence of an excess of added free haemin, the yield of 
biliverdin far exceeded the original haem content of 
the haemoprotein and the specificity of cleavage was 
retained (o bridge only in myoglobin; Q and fl in haemo- 
globin). A typical result obtained with myoglobin is 
illustrated in fig. 1. 
Since haemin itself is not degraded at a significant 
rate under the conditions used (fig. l), these results 
indicate that the apo-haemproteins cleave the added 
free haemin with both the specificity and turn-over 
characteristic of enzymes, the haem-binding sites being 
equivalent to active sites. 
Exchange of haem between haemoglobin and the 
microsomal cytochrome P450 (via haemopexin) has 
been demonstrated 120,2 1 ] and methaemoglobin loses 
its haem readily to apomyoglobin in vitro [22]. It is 
therefore possible that the haem of haemoglobin, after 
rupture of the senescent erythrocyte, could be cleaved 
entirely to biliverdin IXor by a repetitious cycle of 
breakdown in one of the absolutely o-specific haem- 
proteins, with continuous regeneration of this haem- 
protein by transfer of haem from haemoglobin. The 
breakdown of intraveneously injected free haemin 
[23] could also be accounted for by such a mechanism. 
The recent description [24] of the conversion of hae- 
min to bilirubin by a microsomal system may be ex- 
plained by a similair process, probably involving cyto- 
chromeP450 as postulated above, with a subsequent 
reduction of the biliverdin to bilirubin by biliverdin 
reductase in the extracts. Note that in such a mecha- 
nism we do not envisage cytochrome P450 acting in 
its usual role as a hydroxylase, but rather the apo-pro- 
tein acting as an cw-methine-specific haem oxidase. 
In summary, our results lend strong support to a 
somewhat modified version of the long-standing hypo- 
thesis of Lemberg that coupled oxidation of haempro- 
teins is the basis of the mechanism of in vivo haem 
breakdown. 
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